Table 1 The clinicopathological factors of non-PMO (n = 58) patients and PMO (n = 40)
From: Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis
Characteristics | non-PMO | PMO | P-value |
|---|---|---|---|
Age (year) | 57.35 ± 3.98 | 59.69 ± 5.51 | NS |
BMI (kg/m2) | 24.28 ± 2.79 | 23.8 ± 2.17 | NS |
LS BMD (g/cm3) | 1.19 ± 0.11 | 0.8 ± 0.07 | *** |
FN BMD (g/cm3) | 0.98 ± 0.08 | 0.72 ± 0.1 | *** |
Total hip | 1.02 ± 0.09 | 0.76 ± 0.11 | *** |
E2 (pmol/L) | 45.85 ± 29.35 | 24.42 ± 7.47 | *** |
25(OH)VD (ng/mL) | 50.86 ± 17.7 | 56.28 ± 20.46 | *** |
BGP (ng/mL) | 19.96 ± 7.45 | 24.24 ± 13.25 | NS |
CTX-1 (ng/mL) | 0.38 ± 0.18 | 0.48 ± 0.33 | NS |
P1NP (ng/mL) | 54.92 ± 21.35 | 64.91 ± 43.46 | NS |
PTH (pg/mL) | 45.4 ± 21.59 | 47.65 ± 26.08 | NS |